MAPK pathway inhibitors enhance radioiodine sensitivity in anaplastic thyroid carcinoma through promoting NIS expression and ARF4-mediated NIS membrane transport

Related articles

1. SR-4835, a CDK12 inhibitor, enhances the antitumor efficacy of sunitinib in human renal cell carcinoma through suppression of the ATR-associated DNA damage response pathway: an in vitro and in vivo study

   This article has 12 authors:

   1. Po-Ming Chow
   2. Yi‑Ju Kao
   3. Kuan‑Lin Kuo
   4. Jun‑Ren Dong
   5. Chen-Hsun Hsu
   6. Kuo-Tai Hua
   7. Yu-Lun Huang
   8. Yu‑Wei Chang
   9. Shih-Ming Liao
   10. Shing-Hwa Liu
   11. Wei‑Chou Lin
   12. Kuo-How Huang

2. Nonylphenol Promotes Colorectal Cancer Progression via the ERK–FosB Signaling Pathway

   This article has 4 authors:

   1. Weiwei Ning
   2. Qingxu Yang
   3. Zhengbiao Li
   4. Ming Xie

3. Immunomodulatory impact of PTPN11 /SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer

   This article has 20 authors:

   1. Asma Y. Alrawashdeh
   2. Xun Chen
   3. Philipp Hafner
   4. Steffen J. Keller
   5. Tonmoy Das
   6. Huda Jumaa
   7. Thomas Y. Avery
   8. Solène Besson
   9. Silke Hempel
   10. Stephanie Mewes
   11. Kerstin Meyer
   12. Mohammad Al Shhab
   13. Mara Schneider
   14. Johannes D. Lettner
   15. Dominik von Elverfeldt
   16. Wilfried Reichardt
   17. Melanie Boerries
   18. Stefan Fichtner-Feigl
   19. Geoffroy Andrieux
   20. Dietrich A. Ruess